/Companies

RNA Connect

1 known investors

Find your way into RNA Connect

Sign up to see every warm intro you have to RNA Connect

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the RNA Connect team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

RNA Connect develops uMRT, a reverse transcriptase enzyme for end-to-end cDNA synthesis that copies full RNA transcripts, including large viral genomes, in a single pass. The technology is aimed at gene expression, regulation, and discovery research applications in the life sciences.

Founders & leadership

AP
Anna PyleFounderAnna Pyle leads research on RNA structure and function, with expertise in viral RNAs, splicing mechanisms, and the protein interactions that govern RNA recognition and processing. Her group employs biophysical and structural methods including crystallography and enzymology to study RNA-binding proteins and RNA-activated motor proteins.
LG
Li-Tao GuoCo-founder & VP of Research and Development
RMRyan Muldoon
Ryan MuldoonCEO

Investors · 1

Related companies · 3

Companies working in the same space as RNA Connect.

Frequently asked questions

What does RNA Connect do?
RNA Connect develops uMRT, a reverse transcriptase enzyme for end-to-end cDNA synthesis that copies full RNA transcripts, including large viral genomes, in a single pass. The technology is aimed at gene expression, regulation, and discovery research applications in the life sciences.
Who founded RNA Connect?
RNA Connect was founded by Anna Pyle, Li-Tao Guo.
Who are RNA Connect's investors?
RNA Connect's investors include Connecticut Innovations.